CWM
ARKG icon

Concentrum Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Concentrum Wealth Management’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-39,454
Closed -$1.23M – 38
2020
Q1 		$1.23M Buy
+39,454
New +$1.32M 1.66% 12

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CFA
Carroll Financial Associates Charlotte, North Carolina $1.88B AUM 20.52% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
CAN
Claraphi Advisory Network Aliso Viejo, United States $251M AUM 9.29% 1-Year Est. Return
LFA
Legend Financial Advisors Pittsburgh, Pennsylvania $176M AUM 57.06% 1-Year Est. Return

Concentrum Wealth Management's ARKG Position: Q2 2020 in Review

Concentrum Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2020, closing a stake of 39,454 shares — an estimated $1.23M sold.

Concentrum Wealth Management first reported a position in ARKG in Q1 2020 and held it in 1 quarter. The position peaked at $1.23M in Q1 2020. 168 funds tracked by Wall St. Rank hold ARKG as of Q2 2020.

  • Concentrum Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q2 2020 after selling out during the quarter.
  • Concentrum Wealth Management sold 39,454 ARK Genomic Revolution ETF shares in Q2 2020, an estimated $1.23M.
  • Concentrum Wealth Management first reported a position in ARK Genomic Revolution ETF in Q1 2020 and held it in 1 quarter.
  • Concentrum Wealth Management's ARK Genomic Revolution ETF position peaked at $1.23M in Q1 2020.
  • 168 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2020.

Based on Concentrum Wealth Management's 13F filing for Q2 2020, filed 6 Aug 2020.